| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/14/2011 | US20110172257 (poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents |
| 07/14/2011 | US20110172254 Folate receptor binding conjugates of antifolates |
| 07/14/2011 | US20110172253 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 07/14/2011 | US20110172250 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
| 07/14/2011 | US20110172245 Heterocyclic compound and use thereof |
| 07/14/2011 | US20110172241 Benzazole analogues and uses thereof |
| 07/14/2011 | US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease |
| 07/14/2011 | US20110172234 Methods and compositions of trail-death receptor agonists/activators |
| 07/14/2011 | US20110172233 Sonic hedgehog modulators |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
| 07/14/2011 | US20110172226 Novel hydrazide containing taxane conjugates |
| 07/14/2011 | US20110172224 Novel heterocycles |
| 07/14/2011 | US20110172221 Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof |
| 07/14/2011 | US20110172220 Discodermolide analogues and methods of their use |
| 07/14/2011 | US20110172219 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172215 Benzene Sulfonamide Thiazole And Oxazole Compounds |
| 07/14/2011 | US20110172213 Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| 07/14/2011 | US20110172212 Amine-based compound and use thereof |
| 07/14/2011 | US20110172203 Substituted Imidazopyridinyl-Aminopyridine Compounds |
| 07/14/2011 | US20110172199 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110172192 Method and compositions for treating hematological malignancies |
| 07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
| 07/14/2011 | US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use |
| 07/14/2011 | US20110172185 Therapeutic drug for adult t-cell leukemia |
| 07/14/2011 | US20110172184 Antitumor agent containing 4 - [[3,5 - bis (trimethylsilyl) benzoyl] amino] benzoic acid |
| 07/14/2011 | US20110172181 Compositions and Methods of Aloe Polysaccharides |
| 07/14/2011 | US20110172163 Novel Protease Inhibitors |
| 07/14/2011 | US20110172162 Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172150 Tissue regeneration method |
| 07/14/2011 | US20110172145 Antimicrobial compounds |
| 07/14/2011 | US20110172143 Method of modulating cell survival and reagents useful for same |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110171727 Compositions and methods for activating genes of interest |
| 07/14/2011 | US20110171323 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer |
| 07/14/2011 | US20110171307 Methods and products for treatment of diseases |
| 07/14/2011 | US20110171301 F, G, H, I and K Crystal Forms of Imatinib Mesylate |
| 07/14/2011 | US20110171296 Method and preparation for binding acetaldehyde in saliva, the stomach and the large intestine |
| 07/14/2011 | US20110171292 Peptide compositions and methods of use |
| 07/14/2011 | US20110171289 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents |
| 07/14/2011 | US20110171261 Immunogenic composition |
| 07/14/2011 | US20110171259 Novel Compositions and Adjuvants |
| 07/14/2011 | US20110171257 Herpes simplex virus amplicon vectors derived from primary isolates |
| 07/14/2011 | US20110171255 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171240 Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171229 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171219 Treating cancer stem cells using targeted cargo proteins |
| 07/14/2011 | US20110171213 Methods for treating pancreatic cancer |
| 07/14/2011 | US20110171211 Heat shock protein gp96 vaccination and methods of using same |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171208 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 07/14/2011 | US20110171206 Antibody combinations and use of same for treating cancer |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171204 Antibodies to ntb-a |
| 07/14/2011 | US20110171203 Methods for treating neoplastic disease targeting o-linked n-acetylglucosamine modifications of cellular protein |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171160 Polymer conjugates of kiss1 peptides |
| 07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
| 07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171126 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
| 07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 07/14/2011 | US20110171124 In situ methods for monitoring the EMT status of tumor cells in vivo |
| 07/14/2011 | CA2823191A1 Apoe peptide dimers and uses thereof |
| 07/14/2011 | CA2822026A1 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | CA2786598A1 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 07/14/2011 | CA2786585A1 Methods and compositions for liquidation of tumors |
| 07/14/2011 | CA2786319A1 Bisphenol derivatives and their use as androgen receptor activity modulators |
| 07/14/2011 | CA2786266A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
| 07/13/2011 | EP2343320A1 GITR binding molecules and uses therefor |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343303A1 PI3-kinase inhibitors |
| 07/13/2011 | EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343297A1 Triazolopyridines |
| 07/13/2011 | EP2343295A1 Triazolopyridine derivates |
| 07/13/2011 | EP2343294A1 Substituted triazolopyridines |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343291A1 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343083A2 Method of selecting patients suitable for WT1 vaccine |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |